Back to VA VANGUARD CAPITAL MANAGEMENT LLC

KYKYNB
2 quarters

Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in KYNTRA BIO INC

Yes. Vanguard Capital Management holds 159,950 shares of KYNB (Kyntra Bio), worth $1.2M, as of its Q2 2026 13F filing. It increased the position by 3,343 shares (+2.1%) from Q1 2026. Vanguard Capital Management has held KYNB in every 13F on record since Q1 2026, 2 quarterly filings.

Current Value

$1.2M

Current Shares

159,950

Total Value Change

+$145,828

Total Shares Change

+3,343

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
159,950
+2.1%
$1.2M0.0%$7.55
18
2026-Q1
First report
156,607
-
$1.1M0.0%$6.78
0

Other major holders of KYNB: VANGUARD GROUP INC, BlackRock, Inc., MARSHALL WACE, LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used